Search - tctmd.com

Displaying 1 - 20 of 60

Sort: Relevancy | Date

News Daily News

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

L.A. McKeown

November 30, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

Shelley Wood

November 30, 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Michael O'Riordan

November 26, 2021

News Daily News

US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access

L.A. McKeown

November 23, 2021

News Daily News

Even in Big Cities, There Are Barriers to TAVI Access

Caitlin E. Cox

November 17, 2021

News Conference News AHA 2021

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

L.A. McKeown

November 13, 2021

Presentation TCT 2021

Prosthetic Valve Selection and Implant Techniques for Prevention of PPM/High Residual Gradients Following SAVR, TAVR, or Valve-in-Valve

Presenter: David Wood

November 06, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

Presentation TCT 2021

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Presenter: Nicolas Van Mieghem

November 05, 2021

Presentation TCT 2021

Case Presentation: 75-Year-Old With Severe AS And Proximal LAD Stenosis - TAVI Alone, TAVI Plus PCI or SAVR Plus CABG?

Presenter: Yousif Ahmad

November 04, 2021

Presentation TCT 2021

Case Presentation: 65-Year-Old With Severe AS And Bicuspid Valve - SAVR or TAVI?

Presenter: Karim Al-Azizi

November 04, 2021

Presentation TCT 2021

Bioprosthetic Valve Failure: Redo SAVR or ViV TAVR?

Presenter: Kendra Grubb

November 04, 2021

News Daily News

Good TAVI Outcomes in Young Patients, but Population Is Unique

Michael O'Riordan

October 22, 2021

News Conference News EACTS 2021

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

Shelley Wood

October 20, 2021

News Conference News TCT 2021

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

Michael O'Riordan

October 07, 2021

News Daily News

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

Caitlin E. Cox

October 05, 2021

News Daily News

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

Michael O'Riordan

October 01, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2021

Shelley Wood

October 01, 2021

Advertisement

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

TCTMD’s Top 10 Most Popular Stories for November 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access

Even in Big Cities, There Are Barriers to TAVI Access

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

Prosthetic Valve Selection and Implant Techniques for Prevention of PPM/High Residual Gradients Following SAVR, TAVR, or Valve-in-Valve

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Case Presentation: 75-Year-Old With Severe AS And Proximal LAD Stenosis - TAVI Alone, TAVI Plus PCI or SAVR Plus CABG?

Case Presentation: 65-Year-Old With Severe AS And Bicuspid Valve - SAVR or TAVI?

Bioprosthetic Valve Failure: Redo SAVR or ViV TAVR?

Good TAVI Outcomes in Young Patients, but Population Is Unique

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

TCTMD’s Top 10 Most Popular Stories for September 2021

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content